Article Versions Notes

Naka T, Hatanaka Y, Tabata Y, Takasawa A, Akiyama H, Hida Y, Okada H, Hatanaka KC, Mitsuhashi T, Kushitani K, et al. Identification of Novel Diagnostic Markers for Malignant Pleural Mesothelioma Using a Reverse Translational Approach Based on a Rare Synchronous Tumor. Diagnostics. 2022; 12(2):316. https://doi.org/10.3390/diagnostics12020316

Naka, Tomoaki, Yutaka Hatanaka, Yukiko Tabata, Akira Takasawa, Hideo Akiyama, Yasuhiro Hida, Hiromi Okada, Kanako C. Hatanaka, Tomoko Mitsuhashi, Kei Kushitani, and et al. 2022. "Identification of Novel Diagnostic Markers for Malignant Pleural Mesothelioma Using a Reverse Translational Approach Based on a Rare Synchronous Tumor" Diagnostics 12, no. 2: 316. https://doi.org/10.3390/diagnostics12020316

Naka, T., Hatanaka, Y., Tabata, Y., Takasawa, A., Akiyama, H., Hida, Y., Okada, H., Hatanaka, K. C., Mitsuhashi, T., Kushitani, K., Amatya, V. J., Takeshima, Y., Inai, K., Kaga, K., & Matsuno, Y. (2022). Identification of Novel Diagnostic Markers for Malignant Pleural Mesothelioma Using a Reverse Translational Approach Based on a Rare Synchronous Tumor. Diagnostics, 12(2), 316. https://doi.org/10.3390/diagnostics12020316